213 related articles for article (PubMed ID: 21159069)
1. HIV-associated central nervous system diseases in the era of combination antiretroviral therapy.
Tan IL; McArthur JC
Eur J Neurol; 2011 Mar; 18(3):371-2. PubMed ID: 21159069
[No Abstract] [Full Text] [Related]
2. HIV-associated central nervous system diseases in the recent combination antiretroviral therapy era.
; Garvey L; Winston A; Walsh J; Post F; Porter K; Gazzard B; Fisher M; Leen C; Pillay D; Hill T; Johnson M; Gilson R; Anderson J; Easterbrook P; Bansi L; Orkin C; Ainsworth J; Phillips AN; Sabin CA
Eur J Neurol; 2011 Mar; 18(3):527-34. PubMed ID: 21159073
[TBL] [Abstract][Full Text] [Related]
3. [HIV and the central nervous system].
Moulignier A
Rev Neurol (Paris); 2006 Jan; 162(1):22-42. PubMed ID: 16446621
[TBL] [Abstract][Full Text] [Related]
4. Incidence proportion of and risk factors for AIDS patients diagnosed with HIV dementia, central nervous system toxoplasmosis, and cryptococcal meningitis.
Wang F; So Y; Vittinghoff E; Malani H; Reingold A; Lewis E; Giordano J; Janssen R
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):75-82. PubMed ID: 8548350
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of neuro-AIDS on a neurological intensive care unit: epidemiology and predictors of outcome].
Braicks O; Anneken K; Reichelt D; Schäbitz WR; Dziewas R; Evers S; Husstedt IW
Nervenarzt; 2011 Oct; 82(10):1290-5. PubMed ID: 21567297
[TBL] [Abstract][Full Text] [Related]
6. Profile of central nervous system disease in HIV/AIDS patients with special reference to cryptococcal infections.
Wadhwa A; Kaur R; Bhalla P
Neurologist; 2008 Jul; 14(4):247-51. PubMed ID: 18617851
[TBL] [Abstract][Full Text] [Related]
7. The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy.
Sacktor N
J Neurovirol; 2002 Dec; 8 Suppl 2():115-21. PubMed ID: 12491162
[TBL] [Abstract][Full Text] [Related]
8. New features of progressive multifocal leukoencephalopathy in the era of highly active antiretroviral therapy and natalizumab.
Lima MA; Koralnik IJ
J Neurovirol; 2005; 11 Suppl 3():52-7. PubMed ID: 16540456
[TBL] [Abstract][Full Text] [Related]
9. [Neurological manifestations of HIV-infection in the era of highly active antiretroviral therapy (HAART)].
Arendt G
Fortschr Neurol Psychiatr; 2005 Oct; 73(10):577-86. PubMed ID: 16217698
[TBL] [Abstract][Full Text] [Related]
10. [Neurological complications of HIV infection: diagnosis and therapy].
Portegies P; Enting RH
Ned Tijdschr Geneeskd; 1994 Jul; 138(30):1507-12. PubMed ID: 8065469
[No Abstract] [Full Text] [Related]
11. HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998.
Sacktor N; Lyles RH; Skolasky R; Kleeberger C; Selnes OA; Miller EN; Becker JT; Cohen B; McArthur JC;
Neurology; 2001 Jan; 56(2):257-60. PubMed ID: 11160967
[TBL] [Abstract][Full Text] [Related]
12. Opportunistic infections of the central nervous system in the course of acquired immune deficiency syndrome (AIDS). Morphological analysis of 172 cases.
Zelman IB; Mossakowski MJ
Folia Neuropathol; 1998; 36(3):129-44. PubMed ID: 9833390
[TBL] [Abstract][Full Text] [Related]
13. Commonly Prescribed Antiretroviral Therapy Regimens and Incidence of AIDS-Defining Neurological Conditions.
Caniglia EC; Phillips A; Porter K; Sabin CA; Winston A; Logan R; Gill J; Vandenhende MA; Barger D; Lodi S; Moreno S; Arribas JR; Pacheco A; Cardoso SW; Chrysos G; Gogos C; Abgrall S; Costagliola D; Meyer L; Seng R; van Sighem A; Reiss P; Muga R; Hoyos SP; Braun D; Hauser C; Barrufet P; Leyes M; Tate J; Justice A; Hernán MA
J Acquir Immune Defic Syndr; 2018 Jan; 77(1):102-109. PubMed ID: 28991888
[TBL] [Abstract][Full Text] [Related]
14. HIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment.
Bowen LN; Smith B; Reich D; Quezado M; Nath A
Nat Rev Neurol; 2016 Oct; 12(11):662-674. PubMed ID: 27786246
[TBL] [Abstract][Full Text] [Related]
15. Neuro-cognitive disorders on the rise.
Link D
GMHC Treat Issues; 1995 Mar; 9(3):7-8. PubMed ID: 11362361
[TBL] [Abstract][Full Text] [Related]
16. Inflammatory progressive multifocal leukoencephalopathy after antiretroviral treatment.
Silva MT; Pacheco MC; Vaz B
AIDS; 2006 Feb; 20(3):469-71. PubMed ID: 16439887
[No Abstract] [Full Text] [Related]
17. HIV-1/AIDS neuropathology in a Canadian teaching centre.
Walsh K; Thompson W; Megyesi J; Wiley CA; Hammond R
Can J Neurol Sci; 2004 May; 31(2):235-41. PubMed ID: 15198450
[TBL] [Abstract][Full Text] [Related]
18. [Central nervous system infections in HIV patients in the era of high activity antiretroviral treatment].
Rivas González P; Fernández Guerrero ML
Rev Clin Esp; 2005 Jun; 205(6):278-82. PubMed ID: 15970136
[TBL] [Abstract][Full Text] [Related]
19. Decreasing incidence of cryptococcal meningitis in West Africa in the era of highly active antiretroviral therapy.
Bamba S; Lortholary O; Sawadogo A; Millogo A; Guiguemdé RT; Bretagne S
AIDS; 2012 May; 26(8):1039-41. PubMed ID: 22552479
[TBL] [Abstract][Full Text] [Related]
20. The clinical profile of end-stage AIDS in the era of highly active antiretroviral therapy.
Welch K; Morse A;
AIDS Patient Care STDS; 2002 Feb; 16(2):75-81. PubMed ID: 11874639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
